Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Fibroblast growth factor (FGF) is a multi-gene family that plays an important role in promoting a variety of physiological and pathological processes, such as embryo development, tissue repair, neuroprotection, tumor genesis, and metastasis. FGFs consist of 23 members with molecular weights ranging from 17×103 to 34×103, and all the FGFs have a conserved core consisting of 120 amino acids. According to the sequence homology and phylogenetic differences, these families can be divided into three types, including parasecretory FGF, endocrine FGF, and cytosecretory FGF. FGF6, as one of its family members, is mainly expressed in skeletal muscle tissue. In addition, FGF6 can not only promote muscle regeneration but also accelerate the proliferation and differentiation of muscle cells, exhibiting its potential clinical value. FGF6 has also been found to be expressed in the muscles of the mouth, tongue, pharynx, and neck. In adult testes, FGF6 transcripts have also been detected, but the important role of FGF6 in human prostate cancer needs to be further studied. Other studies have found that FGF6 can promote the proliferation of cardiomyocytes and protect cardiomyocytes from apoptosis. In conclusion, FGF6 has a variety of biological functions in angiogenesis, bone formation, tongue development, and other aspects.
Muscle regeneration enhanced by FGF6
Skeletal muscle injury is one of the most common injuries in sports medicine. The study of skeletal muscle repair and regeneration is of great clinical significance in the field of treatment and rehabilitation after skeletal muscle injury. The skeletal muscle that is damaged severely has remarkable regenerative capacity. Skeletal muscle regeneration is maintained by satellite cells. The satellite cells of mature skeletal muscle are normally stationary but they become activated after injury. The relative research has shown that FGF6 of wild-type mice will be up-regulated after skeletal muscle injury, which promotes a complete recovery of the experimentally damaged skeletal muscle. The protective effect on skeletal muscle and the effect on the proliferation and differentiation due to the change of FGF6 expression has been studied by Wu’s group. They demonstrated that the viability and migration of C2C12 have been promoted by FGF6. FGF6 at Low concentrations has promoted myoblast differentiation through the activation of ERK1/2 mediated by FGFR4. These results indicated that skeletal muscle atrophy was reduced by FGF6 based on the ERK1/2 mechanism, and the conversion from slow muscle to fast muscle fibers has been further enhanced by FGF6, thereby promoting the good recovery of regenerated skeletal muscle.
FGF6 associated with early mouse tongue development
The tongue is one of the highly flexible organs that is important for multiple human actions, such as speaking, chewing, and swallowing. FGF signaling is reported to play a vital role in tongue development by Klein’s group. They have demonstrated that FGF6 controls myoblast differentiation and myoblast fusion during tongue development. They have also investigated the expression of different FGF members during early tongue development, including FGF5-7, FGF9, Fgf10, Fgf16, and Fgf18. It is shown that the expression of FGF6 was at low levels in E11.5 and E12.5, but it was significantly up-regulated from E13.5, suggesting the great function of FGF6 in the tongue differentiation period. All the results have given powerful evidence that FGF6 can act as a downstream of TGFβ signaling mediated by SMAD4 to control myoblast differentiation and myoblast fusion during tongue myogenesis.
Figure 1. Scheme model for explaining the mechanism of FGF6/FGF9-mediated Ucp1 expression (Shamsi et al., 2020).
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.